Evidence map›Paper›PMID 42599354›Full record

ReviewWorld journal of microbiology & biotechnology2026

Non canonical perspectives on AmpR mediated ampC expression in Gram negative bacteria, with particular emphasis on the potential regulatory purview of FtsZ.

Sachin Kumar Gupta, Ananya Anurag Anand, Sarfraz Anwar, Sreyanki Chandra, Ayush Amod, Sintu Kumar Samanta

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sachin Kumar GuptaDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, 211012, Uttar Pradesh, India.
Ananya Anurag AnandDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, 211012, Uttar Pradesh, India.
Sarfraz AnwarDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, 211012, Uttar Pradesh, India.
Sreyanki ChandraDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, 211012, Uttar Pradesh, India.
Ayush AmodDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, 211012, Uttar Pradesh, India.
Sintu Kumar SamantaDepartment of Applied Sciences, Indian Institute of Information Technology Allahabad, Prayagraj, 211012, Uttar Pradesh, India. samantasintu@iiita.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Lactamases (BLs) are a principal cause of antimicrobial resistance in Gram-negative bacteria, hydrolysing β-lactam antibiotics and rendering them ineffective. Among these, the chromosomally encoded AmpC is unusual: unlike plasmid-borne BLs, its expression is tightly and inducibly controlled by the transcriptional regulator AmpR, which senses peptidoglycan-recycling intermediates and switches from repressor to activator under β-lactam pressure. This review re-examines AmpR not as an isolated genetic switch but as a metabolic sensor that reads the intracellular muropeptide pool and converts it into a proportionate resistance response. Building on this, we propose a conceptual FtsZ-AmpR-AmpC axis: because FtsZ orchestrates septal peptidoglycan remodelling during cell division, it shapes the very muropeptide landscape that AmpR monitors, offering an indirect route by which division dynamics may modulate AmpC induction. This is the first review to frame AmpC regulation in this way. We further note the framework's principal limitations: the FtsZ contribution remains inferential, the physiological AmpR activators are still unidentified and the AmpR-AmpC system is not conserved across all Gram-negative bacteria. Resolving these gaps through time-resolved muropeptide profiling and controlled FtsZ perturbation may reveal new, division-linked vulnerabilities for countering β-lactam resistance.

Indexed as

Bacterial Proteinsbeta-LactamasesCytoskeletal ProteinsGram-Negative Bacteriabeta Lactam AntibioticsGene Expression Regulation, BacterialPeptidoglycanAmpC beta-lactamasesAmpR protein, BacteriaBacterial Proteinsbeta Lactam Antibioticsbeta-LactamasesCytoskeletal ProteinsFtsZ protein, BacteriaPeptidoglycanAmpCAmpRAntimicrobial resistanceBeta-lactamasesFtsZ

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.